B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment
- PMID: 26297738
- DOI: 10.1182/blood-2015-03-634238
B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment
Abstract
Acute lymphoblastic leukemia (ALL) cells reside in the bone marrow microenvironment which nurtures and protects cells from chemotherapeutic drugs. The disruption of cell-cell communication within the leukemic niche may offer an important new therapeutic strategy. Tunneling nanotubes (TNTs) have been described as a novel mode of intercellular communication, but their presence and importance in the leukemic niche are currently unknown. Here, we show for the first time that primary B-cell precursor ALL (BCP-ALL) cells use TNTs to signal to primary mesenchymal stromal cells (MSCs). This signaling results in secretion of prosurvival cytokines, such as interferon-γ-inducible protein 10/CXC chemokine ligand 10, interleukin 8, and monocyte chemotactic protein-1/CC chemokine ligand 2. A combination of TNT-disrupting conditions allows us to analyze the functional importance of TNTs in an ex vivo model. Our results indicate that TNT signaling is important for the viability of patient-derived B-cell precursor ALL cells and induces stroma-mediated prednisolone resistance. Disruption of TNTs significantly inhibits these leukemogenic processes and resensitizes B-cell precursor ALL cells to prednisolone. Our findings establish TNTs as a novel communication mechanism by which ALL cells modulate their bone marrow microenvironment. The identification of TNT signaling in ALL-MSC communication gives insight into the pathobiology of ALL and opens new avenues to develop more effective therapies that interfere with the leukemic niche.
© 2015 by The American Society of Hematology.
Similar articles
-
B-cell precursor acute lymphoblastic leukemia elicits an interferon-α/β response in bone marrow-derived mesenchymal stroma.Haematologica. 2024 Jul 1;109(7):2073-2084. doi: 10.3324/haematol.2023.283494. Haematologica. 2024. PMID: 38426282 Free PMC article.
-
Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells.Int J Hematol. 2020 Dec;112(6):795-806. doi: 10.1007/s12185-020-02981-z. Epub 2020 Aug 30. Int J Hematol. 2020. PMID: 32862292
-
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells.Haematologica. 2019 Mar;104(3):533-545. doi: 10.3324/haematol.2018.188664. Epub 2018 Sep 27. Haematologica. 2019. PMID: 30262563 Free PMC article.
-
Molecular and cellular mechanisms of chemoresistance in paediatric pre-B cell acute lymphoblastic leukaemia.Cancer Metastasis Rev. 2024 Dec;43(4):1385-1399. doi: 10.1007/s10555-024-10203-9. Epub 2024 Aug 5. Cancer Metastasis Rev. 2024. PMID: 39102101 Free PMC article. Review.
-
Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies.Int J Mol Sci. 2020 May 14;21(10):3481. doi: 10.3390/ijms21103481. Int J Mol Sci. 2020. PMID: 32423160 Free PMC article. Review.
Cited by
-
The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.Cell Death Discov. 2022 Sep 26;8(1):397. doi: 10.1038/s41420-022-01193-0. Cell Death Discov. 2022. PMID: 36163119 Free PMC article. Review.
-
Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia.Sci Adv. 2021 Mar 10;7(11):eabd6280. doi: 10.1126/sciadv.abd6280. Print 2021 Mar. Sci Adv. 2021. PMID: 33692103 Free PMC article.
-
A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia.Exp Hematol. 2019 Jan;69:1-10. doi: 10.1016/j.exphem.2018.09.006. Epub 2018 Sep 24. Exp Hematol. 2019. PMID: 30261200 Free PMC article. Review.
-
Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow Niche.Front Oncol. 2022 Jun 29;12:924567. doi: 10.3389/fonc.2022.924567. eCollection 2022. Front Oncol. 2022. PMID: 35847950 Free PMC article. Review.
-
Tunneling Nanotubes and Tumor Microtubes in Cancer.Cancers (Basel). 2020 Apr 1;12(4):857. doi: 10.3390/cancers12040857. Cancers (Basel). 2020. PMID: 32244839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials